Exact Mass: 485.1870172
Exact Mass Matches: 485.1870172
Found 500 metabolites which its exact mass value is equals to given mass value 485.1870172
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Kanamycin X
C18H35N3O12 (485.22206300000005)
A kanamycin that is kanamycin A in which the 6-amino group is replaced by a hydroxy group.
Kanamycin D
C18H35N3O12 (485.22206300000005)
A kanamycin that is kanamycin A in which the 3-amino group is replaced by a hydroxy group.
Ketotifen-N-glucuronide
C25H27NO7S (485.15081520000007)
Ketotifen-N-glucuronide is a metabolite of ketotifen. Ketotifen is a second-generation H1-antihistamine and mast cell stabilizer. It is most commonly sold in as a salt of fumaric acid, ketotifen fumarate, and is available in two forms. In its ophthalmic form, it is used to treat allergic conjunctivitis, or the itchy red eyes caused by allergies. In its oral form, it is used to prevent asthma attacks. Side effects include drowsiness, weight gain, dry mouth, irritability, and increased nosebleeds. (Wikipedia)
Fluoxetine glucuronide
C23H26F3NO7 (485.16612820000006)
Fluoxetine glucuronide is a metabolite of fluoxetine. Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex, among others) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Fluoxetine was first documented in 1974 by scientists from Eli Lilly and Company. It was presented to the U.S. Food and Drug Administration in February 1977, with Eli Lilly receiving final approval to market the drug in December 1987. Fluoxetine went off-patent in August 2001 (Wikipedia).
hydroxynefazodone
hydroxynefazodone is a metabolite of nefazodone. Nefazodone (Serzone, Nefadar) is an antidepressant marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries due to the rare incidence of hepatotoxicity (liver damage), which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in every 250,000 to 300,000 patient-years. On June 14, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States and Canada. (Wikipedia)
5-Biphenyl-4-yl-5-[4-(-nitro-phenyl)-piperazin-1-yl]-pyrimidine-2,4,6-trione
Afatinib
Amrubicinol (mixture)
Canertinib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Erismodegib
C26H26F3N3O3 (485.1926162000001)
p-Hydroxynefazodone
5-[4-(4-Nitrophenyl)piperazin-1-yl]-5-(4-phenylphenyl)-1,3-diazinane-2,4,6-trione
2-[3-[4-(3-Chlorophenyl)piperazin-1-yl]-1-hydroxypropyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one
o2',o3',o5'-Tri-acetyl-n6-(3-hydroxyphenyl)adenosine
Vilanterol
C24H33Cl2NO5 (485.17356680000006)
beta-hydroxyorcein
A member of the class of phenoxazines that is 1,9-dimethyl-3H-phenoxazin-3-one carrying an additional hydroxy substituent at position 7 as well as two 2,4-dihydroxy-6-methylphenyl substituents at positions 2 and 8. The isomer in which the hydroxy groups at positions 2 and 2 on the phenyl rings are both on the same side of the plane of the phenoxazine ring system. A component of orcein, a mixture of dyes isolated from lichens.
3-carboxy-indole-10-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl ester|chaihuxinoside B
C21H27NO12 (485.15331820000006)
(N2,N2-dimethyl-L-phenylalanyl)-N1-(4-hydroxybenzyl)-L-tryptophan
C29H31N3O4 (485.23144460000003)
cypridina luciferin 3-enol sulfate|cypridina luciferin sulfate
C22H27N7O4S (485.1845142000001)
Ala Cys His Arg
C18H31N9O5S (485.21687560000004)
Ala Cys Arg His
C18H31N9O5S (485.21687560000004)
Ala His Cys Arg
C18H31N9O5S (485.21687560000004)
Ala His Met Gln
C19H31N7O6S (485.20564260000003)
Ala His Gln Met
C19H31N7O6S (485.20564260000003)
Ala His Arg Cys
C18H31N9O5S (485.21687560000004)
Ala Met His Gln
C19H31N7O6S (485.20564260000003)
Ala Met Gln His
C19H31N7O6S (485.20564260000003)
Ala Gln His Met
C19H31N7O6S (485.20564260000003)
Ala Gln Met His
C19H31N7O6S (485.20564260000003)
Ala Arg Cys His
C18H31N9O5S (485.21687560000004)
Ala Arg His Cys
C18H31N9O5S (485.21687560000004)
Cys Ala His Arg
C18H31N9O5S (485.21687560000004)
Cys Ala Arg His
C18H31N9O5S (485.21687560000004)
Cys His Ala Arg
C18H31N9O5S (485.21687560000004)
Cys His Ile Asn
C19H31N7O6S (485.20564260000003)
Cys His Leu Asn
C19H31N7O6S (485.20564260000003)
Cys His Asn Ile
C19H31N7O6S (485.20564260000003)
Cys His Asn Leu
C19H31N7O6S (485.20564260000003)
Cys His Gln Val
C19H31N7O6S (485.20564260000003)
Cys His Arg Ala
C18H31N9O5S (485.21687560000004)
Cys His Val Gln
C19H31N7O6S (485.20564260000003)
Cys Ile His Asn
C19H31N7O6S (485.20564260000003)
Cys Ile Asn His
C19H31N7O6S (485.20564260000003)
Cys Leu His Asn
C19H31N7O6S (485.20564260000003)
Cys Leu Asn His
C19H31N7O6S (485.20564260000003)
Cys Asn His Ile
C19H31N7O6S (485.20564260000003)
Cys Asn His Leu
C19H31N7O6S (485.20564260000003)
Cys Asn Ile His
C19H31N7O6S (485.20564260000003)
Cys Asn Leu His
C19H31N7O6S (485.20564260000003)
Cys Asn Ser Tyr
Cys Asn Tyr Ser
Cys Gln His Val
C19H31N7O6S (485.20564260000003)
Cys Gln Val His
C19H31N7O6S (485.20564260000003)
Cys Arg Ala His
C18H31N9O5S (485.21687560000004)
Cys Arg His Ala
C18H31N9O5S (485.21687560000004)
Cys Ser Asn Tyr
Cys Ser Tyr Asn
Cys Val His Gln
C19H31N7O6S (485.20564260000003)
Cys Val Gln His
C19H31N7O6S (485.20564260000003)
Cys Tyr Asn Ser
Cys Tyr Ser Asn
Asp His Lys Ser
Asp His Asn Thr
Asp His Gln Ser
Asp His Ser Lys
Asp His Ser Gln
Asp His Thr Asn
Asp Lys His Ser
Asp Lys Ser His
Asp Asn His Thr
Asp Asn Thr His
Asp Gln His Ser
Asp Gln Ser His
Asp Ser His Lys
Asp Ser His Gln
Asp Ser Lys His
Asp Ser Gln His
Asp Thr His Asn
Asp Thr Asn His
Glu His Asn Ser
Glu His Ser Asn
Glu Asn His Ser
Glu Asn Ser His
Glu Ser His Asn
Glu Ser Asn His
Gly His Ser Trp
C22H27N7O6 (485.20227220000004)
Gly His Trp Ser
C22H27N7O6 (485.20227220000004)
Gly Ser His Trp
C22H27N7O6 (485.20227220000004)
Gly Ser Trp His
C22H27N7O6 (485.20227220000004)
Gly Trp His Ser
C22H27N7O6 (485.20227220000004)
Gly Trp Ser His
C22H27N7O6 (485.20227220000004)
His Ala Cys Arg
C18H31N9O5S (485.21687560000004)
His Ala Met Gln
C19H31N7O6S (485.20564260000003)
His Ala Gln Met
C19H31N7O6S (485.20564260000003)
His Ala Arg Cys
C18H31N9O5S (485.21687560000004)
His Cys Ala Arg
C18H31N9O5S (485.21687560000004)
His Cys Ile Asn
C19H31N7O6S (485.20564260000003)
His Cys Leu Asn
C19H31N7O6S (485.20564260000003)
His Cys Asn Ile
C19H31N7O6S (485.20564260000003)
His Cys Asn Leu
C19H31N7O6S (485.20564260000003)
His Cys Gln Val
C19H31N7O6S (485.20564260000003)
His Cys Arg Ala
C18H31N9O5S (485.21687560000004)
His Cys Val Gln
C19H31N7O6S (485.20564260000003)
His Asp Lys Ser
His Asp Asn Thr
His Asp Gln Ser
His Asp Ser Lys
His Asp Ser Gln
His Asp Thr Asn
His Glu Asn Ser
His Glu Ser Asn
His Gly Ser Trp
C22H27N7O6 (485.20227220000004)
His Gly Trp Ser
C22H27N7O6 (485.20227220000004)
His Ile Cys Asn
C19H31N7O6S (485.20564260000003)
His Ile Asn Cys
C19H31N7O6S (485.20564260000003)
His Lys Asp Ser
His Lys Ser Asp
His Leu Cys Asn
C19H31N7O6S (485.20564260000003)
His Leu Asn Cys
C19H31N7O6S (485.20564260000003)
His Met Ala Gln
C19H31N7O6S (485.20564260000003)
His Met Gln Ala
C19H31N7O6S (485.20564260000003)
His Asn Cys Ile
C19H31N7O6S (485.20564260000003)
His Asn Cys Leu
C19H31N7O6S (485.20564260000003)
His Asn Asp Thr
His Asn Glu Ser
His Asn Ile Cys
C19H31N7O6S (485.20564260000003)
His Asn Leu Cys
C19H31N7O6S (485.20564260000003)
His Asn Ser Glu
His Asn Thr Asp
His Gln Ala Met
C19H31N7O6S (485.20564260000003)
His Gln Cys Val
C19H31N7O6S (485.20564260000003)
His Gln Asp Ser
His Gln Met Ala
C19H31N7O6S (485.20564260000003)
His Gln Ser Asp
His Gln Thr Thr
His Gln Val Cys
C19H31N7O6S (485.20564260000003)
His Arg Ala Cys
C18H31N9O5S (485.21687560000004)
His Arg Cys Ala
C18H31N9O5S (485.21687560000004)
His Ser Asp Lys
His Ser Asp Gln
His Ser Glu Asn
His Ser Gly Trp
C22H27N7O6 (485.20227220000004)
His Ser Lys Asp
His Ser Asn Glu
His Ser Gln Asp
His Ser Trp Gly
C22H27N7O6 (485.20227220000004)
His Thr Asp Asn
His Thr Asn Asp
His Thr Gln Thr
His Thr Thr Gln
His Val Cys Gln
C19H31N7O6S (485.20564260000003)
His Val Gln Cys
C19H31N7O6S (485.20564260000003)
His Trp Gly Ser
C22H27N7O6 (485.20227220000004)
His Trp Ser Gly
C22H27N7O6 (485.20227220000004)
Ile Cys His Asn
C19H31N7O6S (485.20564260000003)
Ile Cys Asn His
C19H31N7O6S (485.20564260000003)
Ile His Cys Asn
C19H31N7O6S (485.20564260000003)
Ile His Asn Cys
C19H31N7O6S (485.20564260000003)
Ile Asn Cys His
C19H31N7O6S (485.20564260000003)
Ile Asn His Cys
C19H31N7O6S (485.20564260000003)
7-Hydroxyondansetron glucuronide
C24H27N3O8 (485.17980620000003)
Lys Asp His Ser
Lys Asp Ser His
Lys His Asp Ser
Lys His Ser Asp
Lys Ser Asp His
Lys Ser His Asp
Leu Cys His Asn
C19H31N7O6S (485.20564260000003)
Leu Cys Asn His
C19H31N7O6S (485.20564260000003)
Leu His Cys Asn
C19H31N7O6S (485.20564260000003)
Leu His Asn Cys
C19H31N7O6S (485.20564260000003)
Leu Asn Cys His
C19H31N7O6S (485.20564260000003)
Leu Asn His Cys
C19H31N7O6S (485.20564260000003)
Met Ala His Gln
C19H31N7O6S (485.20564260000003)
Met Ala Gln His
C19H31N7O6S (485.20564260000003)
Met His Ala Gln
C19H31N7O6S (485.20564260000003)
Met His Gln Ala
C19H31N7O6S (485.20564260000003)
Met Gln Ala His
C19H31N7O6S (485.20564260000003)
Met Gln His Ala
C19H31N7O6S (485.20564260000003)
Asn Cys His Ile
C19H31N7O6S (485.20564260000003)
Asn Cys His Leu
C19H31N7O6S (485.20564260000003)
Asn Cys Ile His
C19H31N7O6S (485.20564260000003)
Asn Cys Leu His
C19H31N7O6S (485.20564260000003)
Asn Cys Ser Tyr
Asn Cys Tyr Ser
Asn Asp His Thr
Asn Asp Thr His
Asn Glu His Ser
Asn Glu Ser His
Asn His Cys Ile
C19H31N7O6S (485.20564260000003)
Asn His Cys Leu
C19H31N7O6S (485.20564260000003)
Asn His Asp Thr
Asn His Glu Ser
Asn His Ile Cys
C19H31N7O6S (485.20564260000003)
Asn His Leu Cys
C19H31N7O6S (485.20564260000003)
Asn His Ser Glu
Asn His Thr Asp
Asn Ile Cys His
C19H31N7O6S (485.20564260000003)
Asn Ile His Cys
C19H31N7O6S (485.20564260000003)
Asn Leu Cys His
C19H31N7O6S (485.20564260000003)
Asn Leu His Cys
C19H31N7O6S (485.20564260000003)
Asn Pro Gln Gln
Asn Gln Pro Gln
Asn Gln Gln Pro
Asn Ser Cys Tyr
Asn Ser Glu His
Asn Ser His Glu
Asn Ser Tyr Cys
Asn Thr Asp His
Asn Thr His Asp
Asn Tyr Cys Ser
Asn Tyr Ser Cys
Pro Asn Gln Gln
Pro Pro Ser Trp
Pro Pro Trp Ser
Pro Gln Asn Gln
Pro Gln Gln Asn
Pro Ser Pro Trp
Pro Ser Trp Pro
Pro Trp Pro Ser
Pro Trp Ser Pro
Gln Ala His Met
C19H31N7O6S (485.20564260000003)
Gln Ala Met His
C19H31N7O6S (485.20564260000003)
Gln Cys His Val
C19H31N7O6S (485.20564260000003)
Gln Cys Val His
C19H31N7O6S (485.20564260000003)
Gln Asp His Ser
Gln Asp Ser His
Gln His Ala Met
C19H31N7O6S (485.20564260000003)
Gln His Cys Val
C19H31N7O6S (485.20564260000003)
Gln His Asp Ser
Gln His Met Ala
C19H31N7O6S (485.20564260000003)
Gln His Ser Asp
Gln His Thr Thr
Gln His Val Cys
C19H31N7O6S (485.20564260000003)
Gln Met Ala His
C19H31N7O6S (485.20564260000003)
Gln Met His Ala
C19H31N7O6S (485.20564260000003)
Gln Asn Pro Gln
Gln Asn Gln Pro
Gln Pro Asn Gln
Gln Pro Gln Asn
Gln Gln Asn Pro
Gln Gln Pro Asn
Gln Ser Asp His
Gln Ser His Asp
Gln Thr His Thr
Gln Thr Thr His
Gln Val Cys His
C19H31N7O6S (485.20564260000003)
Gln Val His Cys
C19H31N7O6S (485.20564260000003)
Arg Ala Cys His
C18H31N9O5S (485.21687560000004)
Arg Ala His Cys
C18H31N9O5S (485.21687560000004)
Arg Cys Ala His
C18H31N9O5S (485.21687560000004)
Arg Cys His Ala
C18H31N9O5S (485.21687560000004)
Arg His Ala Cys
C18H31N9O5S (485.21687560000004)
Arg His Cys Ala
C18H31N9O5S (485.21687560000004)
Ser Cys Asn Tyr
Ser Cys Tyr Asn
Ser Asp His Lys
Ser Asp His Gln
Ser Asp Lys His
Ser Asp Gln His
Ser Glu His Asn
Ser Glu Asn His
Ser Gly His Trp
C22H27N7O6 (485.20227220000004)
Ser Gly Trp His
C22H27N7O6 (485.20227220000004)
Ser His Asp Lys
Ser His Asp Gln
Ser His Glu Asn
Ser His Gly Trp
C22H27N7O6 (485.20227220000004)
Ser His Lys Asp
Ser His Asn Glu
Ser His Gln Asp
Ser His Trp Gly
C22H27N7O6 (485.20227220000004)
Ser Lys Asp His
Ser Lys His Asp
Ser Asn Cys Tyr
Ser Asn Glu His
Ser Asn His Glu
Ser Asn Tyr Cys
Ser Pro Pro Trp
Ser Pro Trp Pro
Ser Gln Asp His
Ser Gln His Asp
Ser Trp Gly His
C22H27N7O6 (485.20227220000004)
Ser Trp His Gly
C22H27N7O6 (485.20227220000004)
Ser Trp Pro Pro
Ser Tyr Cys Asn
Ser Tyr Asn Cys
Thr Asp His Asn
Thr Asp Asn His
Thr His Asp Asn
Thr His Asn Asp
Thr His Gln Thr
Thr His Thr Gln
Thr Asn Asp His
Thr Asn His Asp
Thr Gln His Thr
Thr Gln Thr His
Thr Thr His Gln
Thr Thr Gln His
Val Cys His Gln
C19H31N7O6S (485.20564260000003)
Val Cys Gln His
C19H31N7O6S (485.20564260000003)
Val His Cys Gln
C19H31N7O6S (485.20564260000003)
Val His Gln Cys
C19H31N7O6S (485.20564260000003)
Val Gln Cys His
C19H31N7O6S (485.20564260000003)
Val Gln His Cys
C19H31N7O6S (485.20564260000003)
Trp Gly His Ser
C22H27N7O6 (485.20227220000004)
Trp Gly Ser His
C22H27N7O6 (485.20227220000004)
Trp His Gly Ser
C22H27N7O6 (485.20227220000004)
Trp His Ser Gly
C22H27N7O6 (485.20227220000004)
Trp Pro Pro Ser
Trp Pro Ser Pro
Trp Ser Gly His
C22H27N7O6 (485.20227220000004)
Trp Ser His Gly
C22H27N7O6 (485.20227220000004)
Trp Ser Pro Pro
Tyr Cys Asn Ser
Tyr Cys Ser Asn
Tyr Asn Cys Ser
Tyr Asn Ser Cys
Tyr Ser Cys Asn
Tyr Ser Asn Cys
1-deoxy-1-[methyl[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]amino]-b-D-Glucopyranuronic acid
C23H26F3NO7 (485.16612820000006)
Carbamic acid, N-[1-[4-(5-chloro-3-phenyl-1,6-naphthyridin-2-yl)phenyl]cyclobutyl]-, 1,1-dimethylethyl ester
C29H28ClN3O2 (485.18699380000004)
Imiclopazine
C25H32ClN5OS (485.20159720000004)
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
4-(2-[(6-Methoxy-3-pyridinyl)amino]-5-{[4-(methylsulfonyl)-1-pipe razinyl]methyl}-3-pyridinyl)-6-methyl-1,3,5-triazin-2-amine
L-Aspartic acid dibenzyl ester 4-toluenesulfonate
C25H27NO7S (485.15081520000007)
Fmoc-Cys(tert-butoxycarnylpropyl)-OH
C26H31NO6S (485.18719860000004)
2-amino-9-((1S,3R,4S)-3-((benzyloxy)methyl)-4-(dimethyl(phenyl)silyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one
afatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents (E/Z)-Afatinib ((E/Z)-BIBW 2992) is the mixture of (E)-Afatinib and (Z)-Afatinib. Afatinib (HY-10261) is an irreversible inhibitor of EGFR, by irreversibly binding to their ATP binding site to block activation of EGFR, HER2, HER4, and EGFRvIII. Afatinib used in co-administration with Temozolomide (HY-17364), potently targeting to EGFRvIII-cMet signaling in glioblastoma cells[1]. Afatinib (BIBW 2992) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-[4-(1-methylethyl)phenyl]- (9CI)
N-[2-[4-[ethyl-[3-(methoxymethyl)pyridin-2-yl]amino]piperidine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide
C24H31N5O4S (485.20966460000005)
N-[1,1-Biphenyl]-4-yl-9,9-diphenyl-9H-fluoren-2-amine
Vilanterol
C24H33Cl2NO5 (485.17356680000006)
An organochlorine compound that is used in the form of its trifenate salt for treatment of chronic obstructive pulmonary disease. C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Vilanterol (GW642444) is a long-acting β2-adrenoceptor (β2-AR) agonist with 24 h activity. The pEC50s for β2-AR,β1-AR and β3-AR is 10.37±0.05, 6.98±0.03 and 7.36±0.03, respectively.
Prucalopride Succinate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D054368 - Laxatives Prucalopride succinate is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride succinate improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride succinate also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride succinate can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer[1][2][3][4].
N-(2,4-dimethoxyphenyl)-3-oxo-2-[[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenyl]azo]butyramide
Sonidegib
C26H26F3N3O3 (485.1926162000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XJ - Hedgehog pathway inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3R)-tetrahydro-3-furanyloxy]-6-quinazolinyl}-4-(dimethylamino)-2-butenamide
N-([1,1-biphenyl]-3-yl)-9,9-diphenyl-9H-fluoren-amine
N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1-biphenyl]-4-amine
Iberdomide hydrochloride
C25H28ClN3O5 (485.17173880000007)
C308 - Immunotherapeutic Agent
4-(2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)aMino)-1-hydroxyethyl)-2-(hydroxyMethyl)phenol
C24H33Cl2NO5 (485.17356680000006)
5-[4-(4-Nitrophenyl)piperazin-1-yl]-5-(4-phenylphenyl)-1,3-diazinane-2,4,6-trione
N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide
PDGF Receptor Tyrosine Kinase Inhibitor III
C27H27N5O4 (485.20629420000006)
(Z)-3-(1,3-benzothiazol-2-yl)-4-(3-methoxyphenyl)-N-(4-morpholinophenyl)but-3-enamide
C28H27N3O3S (485.1773032000001)
gamma-Hydroxyorcein
A member of the class of phenoxazines that is 1,9-dimethyl-3H-phenoxazin-3-one carrying an additional hydroxy substituent at position 7 as well as two 2,4-dihydroxy-6-methylphenyl substituents at positions 2 and 8. The isomer in which the hydroxy groups at positions 2 and 2 on the phenyl rings are situated on opposite sides of the plane of the phenoxazine ring system. A component of orcein, a mixture of dyes isolated from lichens.
N-[1-(Aminomethyl)cyclopropyl]-3-(benzylsulfonyl)-N~2~-[(1S)-2,2,2-trifluoro-1-(4-hydroxyphenyl)ethyl]-L-alaninamide
C22H26F3N3O4S (485.1596032000001)
N-[2-[(cyclohexylamino)-oxomethyl]phenyl]-4-methyl-3-(4-morpholinylsulfonyl)benzamide
C25H31N3O5S (485.19843160000005)
3-[(E)-{2-[4-(morpholin-4-yl)-6-(phenylamino)-1,3,5-triazin-2-yl]hydrazinylidene}methyl]phenyl furan-2-carboxylate
C25H23N7O4 (485.18114380000003)
N-[5-(diethylsulfamoyl)-2-(4-morpholinyl)phenyl]-2-oxo-1-benzopyran-3-carboxamide
C24H27N3O6S (485.1620482000001)
2-[[4-amino-5-(3,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]thio]-1-(1H-indol-3-yl)-2-phenylethanone
C26H23N5O3S (485.15215280000007)
4-amino-N5-[1-(2-furanyl)-2-(3-methylbutylamino)-2-oxoethyl]-N5-(2-methoxyphenyl)isothiazole-3,5-dicarboxamide
C23H27N5O5S (485.1732812000001)
(2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-N-(phenylmethyl)-3,4-dihydro-2H-pyran-6-carboxamide
C29H27NO4S (485.1660702000001)
4-[[(4-acetyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfonylamino]methyl]-N-(3-methylphenyl)-1-cyclohexanecarboxamide
C25H31N3O5S (485.19843160000005)
(2S,3S,4S,5R)-6-[2-cyano-2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C23H27N5O7 (485.19103920000003)
3-(p-carboxyphenylazo)-N-acetyl-L-tyrosylglycylglycine
5-(diaminomethylideneamino)-2-[[4-(5,7-difluoro-2-phenyl-1H-indol-3-yl)-1-oxobutyl]amino]pentanoic acid methyl ester
C25H29F2N5O3 (485.2238348000001)
N-[(5S,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-(2-fluorophenyl)urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
2-[(2R,4aS,12aS)-8-[(2-methoxy-1-oxoethyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(4-fluorophenyl)acetamide
(3R,6aS,8S,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
N-[(4R,7S,8R)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(2-fluorophenyl)urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-(1-methylimidazol-4-yl)sulfonylamino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-(1-methylimidazol-4-yl)sulfonylamino]butyl]urea
(3S,6aR,8S,10aR)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(3S,6aR,8R,10aR)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
N-[(4S,7S,8S)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(5R,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-fluorobenzamide
N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-fluorobenzamide
N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-fluorobenzamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2R,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-propylacetamide
C25H31N3O5S (485.19843160000005)
(3S,6aS,8R,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(2S,3S,3aR,9bR)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H28ClN3O5 (485.17173880000007)
4-[(3aR,4S,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C29H31N3O4 (485.23144460000003)
4-[(3aS,4S,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C29H31N3O4 (485.23144460000003)
[(1S)-7-methoxy-9-methyl-2-methylsulfonyl-1-(5-pyrimidinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C24H31N5O4S (485.20966460000005)
[(1R)-7-methoxy-2-(3-methoxyphenyl)sulfonyl-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O5S (485.19843160000005)
[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(2-pyrazinyl)methanone
C23H27N5O5S (485.1732812000001)
N-[(4R,7S,8S)-5-[(4-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-fluorobenzamide
N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C22H35N3O7S (485.21956000000006)
N-[(5R,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(2S,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2S,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-3-(1-piperidinyl)propyl]amino]-2-oxanyl]ethyl]benzamide
C23H33Cl2N3O4 (485.18479980000006)
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(2-fluorophenyl)urea
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-fluorophenyl)urea
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[(1-methyl-4-imidazolyl)sulfonyl]amino]butyl]urea
(3R,6aS,8R,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(3R,6aR,8R,10aR)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(3S,6aS,8S,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(3R,6aR,8S,10aR)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C22H29Cl2N3O5 (485.14841640000003)
(3aR,4S,9bS)-8-[2-(3-fluorophenyl)ethynyl]-4-(hydroxymethyl)-N-(2-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
4-[(3aS,4R,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C29H31N3O4 (485.23144460000003)
4-[(3aR,4R,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C29H31N3O4 (485.23144460000003)
[(1S)-7-methoxy-2-(3-methoxyphenyl)sulfonyl-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O5S (485.19843160000005)
[(1S)-2-(cyclopropylmethyl)-7-methoxy-9-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H31N5O4S (485.20966460000005)
[(1R)-2-(cyclopropylmethyl)-7-methoxy-9-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H31N5O4S (485.20966460000005)
[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(2-pyrazinyl)methanone
C23H27N5O5S (485.1732812000001)
1-(2-methoxyphenyl)-3-[(E)-(1-methyl-5-piperidin-1-ylsulfonylindol-3-yl)methylideneamino]thiourea
2-amino-4-({2-[(1-carboxy-2-hydroxy-1-methyl-2-phenylethyl)sulfanyl]-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O9S (485.14679320000005)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(2-hydroxy-4-methoxyphenyl)-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H27N3O9S (485.14679320000005)
(2E,5E)-5-benzyl-6-chloro-2-methyl-N-[3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]hexa-2,5-dienamide
C26H32ClN3O2S (485.19036420000003)
3-deamino-3-hydroxykanamycin C
C18H35N3O12 (485.22206300000005)
A kanamycin that is kanamycin C in which the 3-amino group has been replaced by a hydroxy group.
Canertinib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Fluoxetine glucuronide
C23H26F3NO7 (485.16612820000006)
IMM-H007
IMM-H007 (WS070117) is an orally active and potent AMPK (AMP-activated protein kinase) activator and TGFβ1 (transforming growth factor β1) antagonist. IMM-H007 has protective effects in cardiovascular diseases via activation of AMPK. IMM-H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. IMM-H007 inhibits ABCA1 degradation. IMM-H007 resolves hepatic steatosis in HFD-fed hamsters by the regulation of lipid metabolism. IMM-H007 can be used for the research of nonalcoholic fatty liver disease (NAFLD) and inflammatory atherosclerosis[1][2][3]. IMM-H007 (WS070117) is an orally active and potent AMPK (AMP-activated protein kinase) activator and TGFβ1 (transforming growth factor β1) antagonist. IMM-H007 has protective effects in cardiovascular diseases via activation of AMPK. IMM-H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. IMM-H007 inhibits ABCA1 degradation. IMM-H007 resolves hepatic steatosis in HFD-fed hamsters by the regulation of lipid metabolism. IMM-H007 can be used for the research of nonalcoholic fatty liver disease (NAFLD) and inflammatory atherosclerosis[1][2][3].
2-{[2-(3,5-dihydroxyphenyl)-8-hydroxy-3,5,7,9-tetramethyl-6,10-dioxooxecan-4-yl]amino}benzoic acid
(2s,9s,9ar)-2-ethyl-9-hydroxy-9-{[(4r)-3-hydroxy-6-oxo-1-(propan-2-ylidene)-4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-1h,2h,9ah-imidazo[1,2-a]indol-3-one
C27H27N5O4 (485.20629420000006)
(4e)-10,18,18-trichloro-n-(1-hydroxy-3-methoxypropan-2-yl)-n-methyloctadec-4-enamide
C23H42Cl3NO3 (485.2230112000001)